Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award VP, CFO acquired 3,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,000 shares (grant or award)
  4. 4 Grant or award Chairman, Pres & CEO acquired 15,500 shares (grant or award)
  5. 4 Grant or award Director acquired 2,000 shares (grant or award)
  6. 4 Grant or award Director acquired 10,000 shares (grant or award)
  7. 4 Grant or award Director acquired 8,000 shares (grant or award)
  8. 4 Grant or award VP, Chief Financial Officer acquired 8,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy President & CEO bought 1,000 shares at $0.74 ($740)
  11. 4 Open-market buy President & CEO bought 1,000 shares at $0.75 ($750)
  12. 4 Shares withheld for taxes Secretary & VP Finance & Admin gave up 335 shares (to pay taxes)
  13. 4 Open-market buy President & CEO bought 2,500 shares at $0.91 ($2,275)
  14. 4 Shares withheld for taxes President & CEO gave up 1,804 shares (to pay taxes)
  15. 4 Shares withheld for taxes Secretary & VP Finance & Admin gave up 1,181 shares (to pay taxes)
  16. 4 Shares withheld for taxes President & CEO gave up 917 shares (to pay taxes)
  17. 4 Open-market buy President & CEO bought 2,000 shares at an average $2.86 ($5,720)
  18. 4 Open-market buy Director bought 2,000 shares at $3.10 ($6,200)
  19. 4 Shares withheld for taxes Secretary & VP Finance & Admin gave up 335 shares (to pay taxes)
  20. 4 Grant or award Director acquired 1,500 shares (grant or award)

Page 3 of 15 · 281 filings